Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Sensus Healthcare
SRTS
Sensus Healthcare
US Regulations Will Curtail Sales Yet Unveil Opportunities
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
10 Aug 25
Updated
20 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$6.00
45.8% undervalued
intrinsic discount
20 Aug
US$3.25
Loading
1Y
-50.6%
7D
-3.0%
Author's Valuation
US$6.0
45.8% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$6.0
45.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-7m
66m
2014
2017
2020
2023
2025
2026
2028
Revenue US$65.8m
Earnings US$11.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
18.60%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.49%
Calculation
US$11.05m
Earnings '28
x
10.79x
PE Ratio '28
=
US$119.26m
Market Cap '28
US$119.26m
Market Cap '28
/
16.59m
No. shares '28
=
US$7.19
Share Price '28
US$7.19
Share Price '28
Discounted to 2025 @ 7.50% p.a.
=
US$5.79
Fair Value '25
